Document Detail

Pretherapeutic laboratory findings, extent of metastasis and choice of treatment as prognostic markers in ocular melanoma- a single centre experience.
MedLine Citation:
PMID:  23057648     Owner:  NLM     Status:  Publisher    
Background  Uveal melanoma is the most common intraocular neoplasm with a high tendency to metastasize predominantly to the liver. Prognostic parameters for progression and overall survival are not well defined. The aim of this study was to assess the value of pretherapeutic serum levels of C-reactive protein (CRP), lactate dehydrogenase, albumin and fibrinogen in patients with uveal melanoma and to evaluate their significance as prognostic parameters for survival. Methods  Forty-nine patients with metastatic uveal melanoma treated between 2000 and 2010 were retrospectively analysed. The potential influence of levels of CRP, lactate dehydrogenase, fibrinogen and albumin as well as other commonly known prognostic variables on progression-free and overall survival were investigated. Results  Patients' age and treatment with systemic chemotherapy were the only variables to show significant influences on progression-free and overall survival in a univariate analysis. Multivariate analysis confirmed the influence of these variables on progression-free survival, presence of metastasis, pretherapeutic CRP levels and treatment with systemic chemotherapy were associated with overall survival. Conclusion  In this patient cohort elevated pretherapeutic CRP and extent of metastasis are independent prognostic factors for decreased overall survival, whereas treatment with systemic chemotherapy showed a significant association with improved overall survival.
N Schicher; G Edelhauser; K Harmankaya; K Schindler; A Gleiss; H Pehamberger; C Hoeller
Related Documents :
12778388 - Outcome of children with cystic partially differentiated nephroblastoma treated with or...
8790768 - Combined therapy for hypopharyngeal cancer.
20194858 - Outcomes of fertility-sparing surgery for stage i epithelial ovarian cancer: a proposal...
25013718 - Intensive serial biomarker profiling for the prediction of neutropenic fever in patient...
15380578 - Phase i-ii trial of twice-weekly gemcitabine and concomitant irradiation in patients un...
15916568 - Embryonal rhabdomyosarcoma of the tongue.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-12
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  -     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.
Department of Dermatology, Division of General Dermatology Department of Radiology, Division of Cardiovascular and Interventional Radiology Center for Medical Statistics, Informatics and Intelligent Systems Medical University of Vienna, Waehringer Guertel, Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Does Fluoromethane Form a Hydrogen Bond with Water?
Next Document:  Post-cardiac arrest syndrome: Second thoughts regarding therapeutic hypothermia.